welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
-
Laparoscopic Total Colectomy (TPC) for Familial Adenomatous Polyposis – A Case ReportA 30-year-old man was admitted with anem...
-
Food Fit for a J-Pouchhttps://www.youtube.com/watch?v=RxiYAWkx...
-
Preventive Effects of Low-Dose Aspirin on Colorectal Adenoma Growth in Patients with Familial Adenomatous Polyposis:...There are several reports of clinical tr...
-
Nonsteroidal Anti-Inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesNumerous experimental, epidemiologic, an...
-
Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...
-
A Total Laparoscopic Approach Reduces the Infertility Rate after Ileal Pouch-Anal Anastomosis: A 2-Center StudyOBJECTIVE: To assess the infertility ra...
-
Risk-Reducing Surgery in FAP: Role for Surgeons Beyond the IncisionBACKGROUND : Although primary therapy in...